Corrigendum to ‘Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cells’ [Int. J. Parasitol. Drugs Drug Resist. 4 (2014) 14–19]
Main Authors: | Erika van den Bogaart, Gerard J. Schoone, Emily R. Adams, Henk D.F.H. Schallig |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-08-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320716300215 |
Similar Items
-
Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
by: Philip T. LoVerde, et al.
Published: (2022-04-01) -
Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
by: Jessica A. Jesus, et al.
Published: (2017-08-01) -
Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
by: Ana Rita Gomes, et al.
Published: (2017-12-01) -
Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis
by: Lianet Monzote Fidalgo, et al.
Published: (2004-05-01) -
Corrigendum to “Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms” [Int. J. Parasitol. Drugs Drug Resist. 23 (2023) 94–105]
by: Alexandra Kahl, et al.
Published: (2024-12-01)